DOI:
10.1055/s-00050348
Indian Journal of Medical and Paediatric Oncology
LinksClose Window
References
Yadav A, Malik PS, Khurana S. et al.
An open-label randomized controlled trial comparing the efficacy and safety of pemetrexed-carboplatin versus (weekly) paclitaxel-carboplatin as first-line chemotherapy in advanced non-squamous non-small cell lung cancer.
Oncology 2021;
99 (06) 389-396
Access:
Access:
We do not assume any responsibility for the contents of the web pages of other providers.